Literature DB >> 22461471

CLL and deletion 13q14: merely the miRs?

Daniel Mertens1, Stephan Stilgenbauer.   

Abstract

In this issue of Blood, Lia et al present a novel mouse model that recapitulates the pathogenic mechanisms of human CLL with deletion 13q14. Their striking finding is that the size of the deletion correlates with disease penetrance and aggressiveness.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22461471     DOI： 10.1182/blood-2012-01-400747

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  4 in total

Review 1.  Long noncoding RNAs during normal and malignant hematopoiesis.

Authors:  Juan R Alvarez-Dominguez; Wenqian Hu; Austin A Gromatzky; Harvey F Lodish
Journal:  Int J Hematol       Date:  2014-03-09       Impact factor: 2.490

2.  Long non-coding RNA DLEU1 promotes malignancy of breast cancer by acting as an indispensable coactivator for HIF-1α-induced transcription of CKAP2.

Authors:  He Nan Ma; Hai Jun Chen; Ji Quan Liu; Wen Tao Li
Journal:  Cell Death Dis       Date:  2022-07-19       Impact factor: 9.685

3.  TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity.

Authors:  Moshe E Gatt; Kohichi Takada; Mala Mani; Mikael Lerner; Marjorie Pick; Teru Hideshima; Daniel E Carrasco; Alexei Protopopov; Elena Ivanova; Olle Sangfelt; Dan Grandér; Bart Barlogie; John D Shaughnessy; Kenneth C Anderson; Daniel R Carrasco
Journal:  Br J Haematol       Date:  2013-05-07       Impact factor: 6.998

4.  Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.

Authors:  D Allegra; V Bilan; A Garding; H Döhner; S Stilgenbauer; F Kuchenbauer; D Mertens; M Zucknick
Journal:  Leukemia       Date:  2013-08-26       Impact factor: 11.528
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.